Results 241 to 250 of about 908,324 (360)
Advancing Social Life Cycle Assessment: A Novel Approach to Uncertainty Analysis. [PDF]
Cassuriaga B, Santos A, Carvalho A.
europepmc +1 more source
ERα splice variant ERα∆7 lacks the C‐terminus, and its expression may change phenotypes of breast cancers. Our results showed that ERα∆7 is found in the luminal A subtype, and elevated ERα∆7 levels are linked to improved cell survival with lower proliferation and migration.
Long Wai Tsui +10 more
wiley +1 more source
Cost-effectiveness of microprocessor-controlled prosthetic knees in the Dutch healthcare system: The impact of study duration on outcomes. [PDF]
Kuhlmann A, Kannenberg A.
europepmc +1 more source
Life cycle cost modelling of next generation offshore wind farms
Athanasios Kolios
openalex +2 more sources
Development of human monoclonal antibodies against TARM1 by yeast display
Human monoclonal antibodies against TARM1 are generated by yeast display‐guided selection. These antibodies bind to soluble and cell‐surface forms of TARM1. Also, these antibodies exhibit agonistic activity in the NFAT‐GFP reporter assay, indicating that TARM1 signaling can be functionally modulated by antibodies and suggesting TARM1 as a potential ...
Rikio Yabe +5 more
wiley +1 more source
Multiscale computational modeling of the cardiopulmonary consequences of postnatal hyperoxia with implications for preterm-born children. [PDF]
Kim SM +8 more
europepmc +1 more source
Screening and epitope characterization of Nidogen‐2‐specific nanobodies
Camel immunization and phage display were employed to generate high‐affinity VHH nanobodies against Nidogen‐2. After library construction, biopanning, ELISA screening, sequencing, and recombinant expression, selected nanobodies were purified and characterized, leading to the preliminary exploration of a nanobody‐based sandwich ELISA for specific ...
Jianchuan Wen +9 more
wiley +1 more source
A cycle-aware and physics-informed framework for battery remaining useful life prediction. [PDF]
Chen Y, Wu Y, Li C.
europepmc +1 more source

